Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 39501-39550 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05867940
Effects of Physical Activity on Prescription (PAP) as a Health-enhancing Intervention in People With Disabilities
NARecruiting
80 participants
Started: Jun 5, 2023 · Completed: Dec 31, 2027
7 conditions2 sponsors1 location
NCT05842304
Individualized Precision rTMS for Language Recovery in Patients After Ischemic Stroke: a Multi-center RCT
NARecruiting
180 participants
Started: Jun 5, 2023 · Completed: May 10, 2026
2 conditions1 sponsor1 location
NCT05881226
Application of Biomarkers in Neurological Diseases
N/ARecruiting
3,000 participants
Started: Jun 5, 2023 · Completed: Dec 1, 2031
1 condition1 sponsor1 location
NCT05705817
Assistive Soft Skills and Employment Training (ASSET) in TBI Injury
NARecruiting
20 participants
Started: Jun 5, 2023 · Completed: Jun 1, 2024
1 condition1 sponsor1 location
NCT05941962
Use of Hand-held Dynamometry to Obtain Objective Measures of Lower Extremity Force Production With Chronic Stroke
N/ARecruiting
20 participants
Started: Jun 5, 2023 · Completed: Jul 26, 2025
2 conditions1 sponsor1 location
NCT05141149
First in Human Phase1/2a Clinical Trial of Anti-PAUF Monoclonal Antibody PBP1510 in Patients With Pancreatic Cancer
PHASE1/PHASE2Recruiting
80 participants
Started: Jun 5, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor4 locations
NCT05886205
Induced Pluripotent Stem Cell Derived Exosomes Nasal Drops for the Treatment of Refractory Focal Epilepsy
EARLY_PHASE1Recruiting
34 participants
Started: Jun 5, 2023 · Completed: Nov 13, 2025
1 condition2 sponsors1 location
NCT04534530
Does Screening of Coronary Artery Disease an Efficient Public Health Strategy in Patients With Type 2 DIABetes
N/ARecruiting
90,000 participants
Started: Jun 5, 2023 · Completed: Jan 31, 2025
1 condition1 sponsor1 location
NCT05991336
Growth and Development-related Outcomes in Children With Transfusion-dependent Beta-thalassemia After Gene Therapy
N/ARecruiting
100 participants
Started: Jun 5, 2023 · Completed: Dec 31, 2029
2 conditions1 sponsor1 location
NCT05815745
"Physiological vs Right Ventricular Pacing Outcome Trial Evaluated for bradyCardia Treatment (PROTECT-HF)"
NARecruiting
2,600 participants
Started: Jun 5, 2023 · Completed: Dec 4, 2029
5 conditions2 sponsors45 locations
NCT05378841
Efficacy of Surgical Joint Denervation in Painful Digital Osteoarthritis
NARecruiting
19 participants
Started: Jun 5, 2023 · Completed: Jun 15, 2026
1 condition1 sponsor1 location
NCT06191900
Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors (advanced Cervical Cancer)
NARecruiting
26 participants
Started: Jun 5, 2023 · Completed: Jun 5, 2026
2 conditions1 sponsor1 location
NCT05887752
Hunova® Randomized Controlled Trial for Trunk Control Improvement in Spinal Cord Injured Patients
NARecruiting
78 participants
Started: Jun 5, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05728281
Impact of Time on Sexual Function (FSFI® Score) After Hysterectomy
NARecruiting
142 participants
Started: Jun 5, 2023 · Completed: Oct 5, 2026
2 conditions1 sponsor1 location
NCT05974618
Prospective Validation of the ADNEX Model for Discrimination Between Benign and Malignant Adnexal Masses in Pregnancy: International Ovarian Tumour Analysis in Pregnancy Study (p-IOTA)
N/ARecruiting
1,000 participants
Started: Jun 5, 2023 · Completed: Jul 31, 2026
4 conditions1 sponsor1 location
NCT06006039
The Role of IL-23-Responsive Immune Cell Subsets in Post-Operative Recurrence in Patients With Crohn's Disease.
N/ARecruiting
40 participants
Started: Jun 5, 2023 · Completed: Nov 1, 2027
1 condition1 sponsor2 locations
NCT05637762
Development of a Seizure Detection Algorithm Based on Heart Rate and Movement Analysis
N/ARecruiting
10 participants
Started: Jun 5, 2023 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT05303519
Safusidenib Phase 2 Study in IDH1 Mutant Glioma
PHASE2Recruiting
125 participants
Started: Jun 5, 2023 · Completed: Mar 1, 2028
5 conditions2 sponsors31 locations
NCT05123040
Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids
PHASE1/PHASE2Recruiting
55 participants
Started: Jun 5, 2023 · Completed: Sep 30, 2028
1 condition1 sponsor1 location
NCT07207486
In-depth Analysis of Cholesterol Metabolism and Related Biomarkers in the Pathogenesis and Progression of the Disease in Neurodegenerative Dementias
N/ARecruiting
80 participants
Started: Jun 5, 2023 · Completed: Apr 29, 2027
2 conditions3 sponsors2 locations
NCT05848739
A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors
PHASE1Recruiting
130 participants
Started: Jun 5, 2023 · Completed: May 31, 2027
2 conditions1 sponsor11 locations
NCT05908409
A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies
PHASE1/PHASE2Recruiting
37 participants
Started: Jun 5, 2023 · Completed: Mar 22, 2026
6 conditions1 sponsor11 locations
NCT06179953
Emotional Skills Training with Social Robot
NARecruiting
20 participants
Started: Jun 5, 2023 · Completed: Apr 24, 2025
1 condition2 sponsors1 location
NCT05939687
Prophylactic Mesh Placement During Stoma Closure After Low Anterior Resection
PHASE3Recruiting
142 participants
Started: Jun 5, 2023 · Completed: Dec 1, 2028
4 conditions1 sponsor1 location
NCT05484804
Accountability for Care Through Undoing Racism & Equity for Moms
NARecruiting
30,000 participants
Started: Jun 5, 2023 · Completed: Aug 31, 2027
6 conditions4 sponsors1 location
NCT06268561
Ozurdex Endophtamitis Cohort, Prognostic Assessment at 12 Months
N/ARecruiting
8 participants
Started: Jun 5, 2023 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT06339541
The ACC Preclinical Research Platform for Precision Oncology
N/ARecruiting
250 participants
Started: Jun 5, 2023 · Completed: Dec 1, 2024
2 conditions2 sponsors1 location
NCT05910762
Human Learning of New Structured Information Across Time and Sleep
NARecruiting
105 participants
Started: Jun 5, 2023 · Completed: Mar 31, 2028
4 conditions2 sponsors1 location
NCT05885516
Double vs Single Intrauterine Insemination in Male Factor Infertility
NARecruiting
264 participants
Started: Jun 5, 2023 · Completed: Dec 22, 2024
1 condition1 sponsor1 location
NCT05797168
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
PHASE1/PHASE2Recruiting
506 participants
Started: Jun 5, 2023 · Completed: Jan 6, 2028
3 conditions1 sponsor60 locations
NCT05872737
FAB Programme for Parents of Children With NDD
NARecruiting
154 participants
Started: Jun 5, 2023 · Completed: Sep 8, 2026
7 conditions2 sponsors2 locations
NCT05777499
MUSic Therapy In Complex Specialist Neurorehabilitation
NARecruiting
75 participants
Started: Jun 5, 2023 · Completed: Oct 31, 2025
9 conditions3 sponsors1 location
NCT05866952
Ventilatory and Perfusion Abnormalities in Individuals With Post-Acute Sequelae of SARS-CoV-2 Infection
N/ARecruiting
40 participants
Started: Jun 5, 2023 · Completed: Dec 31, 2026
4 conditions2 sponsors1 location
NCT06410092
Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of FTL001
PHASE1Recruiting
44 participants
Started: Jun 5, 2023 · Completed: Mar 31, 2027
1 condition1 sponsor3 locations
NCT05676580
Risk Factors and Progression of Keratoconus
NARecruiting
200 participants
Started: Jun 5, 2023 · Completed: May 31, 2028
1 condition1 sponsor1 location
NCT05762419
FUS Etoposide for DMG
PHASE1Recruiting
10 participants
Started: Jun 5, 2023 · Completed: Dec 31, 2027
2 conditions2 sponsors1 location
NCT05745194
Influence of Nutrition in Depression Treatment (INDEPT)
NARecruiting
190 participants
Started: Jun 5, 2023 · Completed: Dec 31, 2025
1 condition4 sponsors2 locations
NCT06402188
ColoSeal™ ICD System Safety and Feasibility Study
NARecruiting
15 participants
Started: Jun 5, 2023 · Completed: Mar 31, 2025
1 condition1 sponsor2 locations
NCT05375513
SYNERGIC-2 Trial (SYNchronizing, Exercises and Remedies to GaIn Cognition@home)
NARecruiting
275 participants
Started: Jun 5, 2023 · Completed: Dec 30, 2026
1 condition1 sponsor8 locations
NCT05942456
Soluble B7-H3 as a Biomarker for Osteosarcoma
N/ARecruiting
200 participants
Started: Jun 5, 2023 · Completed: Dec 31, 2024
4 conditions1 sponsor1 location
NCT05084196
Melatonin for Prevention of Kidney Injury
PHASE3Recruiting
300 participants
Started: Jun 5, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor2 locations
NCT06203652
The Pathogenesis and Prognostic Factors of Lymphoma
N/ARecruiting
2,000 participants
Started: Jun 5, 2023 · Completed: Dec 31, 2028
3 conditions1 sponsor1 location
NCT06405776
Effect of Lidocaine on Postoperative Pain and Long-term Survival in Elderly Patients Undergoing Colorectal Surgery
NARecruiting
276 participants
Started: Jun 5, 2023 · Completed: Jun 1, 2027
1 condition1 sponsor1 location
NCT05316532
Novel ECCO2R Device for Hypercapnic Respiratory Failure
N/ARecruiting
60 participants
Started: Jun 5, 2023 · Completed: Dec 31, 2025
1 condition4 sponsors1 location
NCT07202351
Targeted Intervention on Sleep Disorders During Tobacco or Cannabis Cessation Therapy
NARecruiting
80 participants
Started: Jun 5, 2023 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT05871762
Choice of the Optimal Treatment Strategies for Mid-low REctal Cancer
N/ARecruiting
3,705 participants
Started: Jun 4, 2023 · Completed: May 17, 2027
1 condition1 sponsor1 location
NCT06597578
Prospective Köln Bonn Registry for the Extraction of Pacmaker and ICD Leads
N/ARecruiting
200 participants
Started: Jun 4, 2023 · Completed: Dec 31, 2027
3 conditions1 sponsor1 location
NCT05199051
A Phase 2 Study of Gemtuzumab Ozogamicin (GO)-Gilteritinib Combination in Adults with FLT3-ITD Relapse/refractory (R/R) AML
PHASE2Recruiting
50 participants
Started: Jun 3, 2023 · Completed: Mar 15, 2027
1 condition4 sponsors30 locations
NCT05846425
Investigating the Effect of Yoga-based Breathing Styles on the Human Brain, With a Focus on Memory
NARecruiting
75 participants
Started: Jun 3, 2023 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT05487131
Neuromodulation and Fatigue
NARecruiting
40 participants
Started: Jun 3, 2023 · Completed: Dec 29, 2025
2 conditions1 sponsor1 location